New Medication for Lung Cancer: Latest Treatments and Innovations You Need to Know
Introduction Lung cancer is one of the most common and serious types of cancer, but…
News
Padcev: A New Hope For Patients With Metastatic Urothelial Cancer
In the field of cancer treatment, targeted therapies and antibody-drug conjugates (ADCs) are emerging as…
FDA Approval Of CAR-T Therapy Carvykti Offers New Hope For Multiple Myeloma Patients
Recently, the U.S. Food and Drug Administration (FDA) officially approved Carvykti (Ciltacabtagene Autoleucel, or Cilta-cel),…
Novel Hemophilia Treatment Turoctocog Alfa Pegol Approved By FDA, Bringing New Hope To Patients
Recently, the U.S. Food and Drug Administration (FDA) officially approved Turoctocog Alfa Pegol (brand name:…
Mavacamten Capsules: Mechanism of Action, Side Effects, Cost, and Clinical Trials
Mavacamten Capsules, a revolutionary drug for treating obstructive hypertrophic cardiomyopathy (HCM), is gaining attention due…
New Immunotherapy Drugs: Iparomlimab And Tuvonralimab Injection Show Promising Results In Clinical Trials
February 25, 2025 – In an exciting advancement in immunotherapy, the combination of Iparomlimab and…
Janagliflozin (Ganagliflozin Proline Tablets): Mechanism of Action and Clinical Insights
Janagliflozin, also known as Ganagliflozin Proline Tablets, marketed under the brand name HuiYouJing, is an…
Ongericimab Injection (JUNSHID®) Approved For Use In China
On October 11, 2024, Junshi Biosciences announced that its self-developed recombinant humanized anti-PCSK9 monoclonal antibody…
Rilonacept Injection: A Breakthrough Treatment For Auto-Inflammatory Disorders
In the fight against severe and chronic auto-inflammatory diseases, Rilonacept Injection has emerged as a…
Mirvetuximab Soravtansine-Gynx Injection: A New Hope For Ovarian Cancer Patients
February 2025 – In a groundbreaking advancement in the treatment of platinum-resistant ovarian cancer, the…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights